Wright Medical Group will not face any enforcement actions from the Securities and Exchange Commission related to foreign sales practices. The SEC’s Division of Enforcement dropped its informal investigation of the medical device maker, according to a government filing.
Wright was one of many medical device makers that came under SEC scrutiny in June 2008 over potential violations of the Foreign Corrupt Practices Act. The Foreign Corrupt Practices Act prohibits U.S. companies from bribing foreign officials to get or keep business. Learn more about the regulation here.